Version 1 du 25 Août 2020
Nullane salus extra ecclesiam
Philippe Gautret, Didier Raoult
Lien vers l’article : https://www.sciencedirect.com/science/article/pii/S2052297520300664
Randomized clinical trials are not relevant for infectious disease outbreaks due to a new pathogen, for which public health decisions have to be made urgently. An approach based on group comparisons, in silico, may provide valuable results in a reasonably short period of time for a negligible amount of money.